Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01052740 · ClinicalTrials.gov registry record

X-Ray Mammography Standard of Care Protocol

A clinical trial of Breast Cancer and Atypical Ductal Hyperplasia, sponsored by National Institutes of Health Clinical Center (CC).

Completed
Registry status
108
Enrollment target
1
Study location

NCT01052740 is a study of Breast Cancer and Atypical Ductal Hyperplasia that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 108 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01052740, a study of Breast Cancer and Atypical Ductal Hyperplasia, has completed, sponsored by National Institutes of Health Clinical Center (CC).

COMPLETED
Registry status
108 participants
Enrollment target
1
Study location

Study Summary

Background: * X-ray mammography is the standard method for breast cancer screening. It is a noninvasive test using x-rays to take pictures of breast tissue and detect any abnormalities. * The National Institutes of Health (NIH) Clinical Center has a breast imaging unit that has been accredited by the American College of Radiology. To maintain accreditation, the unit must recruit a certain number of women to have clinical mammograms each year in order to maintain a high level of clinical skills and experience for the radiologists and technologists. Objectives: \- To create a state-of-the-art mammography unit at the NIH Clinical Center in order to maintain American College of Radiology accreditation of the NIH breast imaging facility. Eligibility: \- Women who are eligible for breast cancer screening because of family cancer history, genetic test results, or previous instances of cancer. Participants may not be pregnant or nursing at the time of the screening. Design: * Participants will provide a brief medical history on arrival at the NIH breast imaging unit. * Each participant will have a standard mammogram performed by a radiology technician. * If the study is normal, participants will be told that no further evaluation will be performed. If the results indicate a need for further imaging or tissue biopsy, participants may elect to return to the care of their primary physician or to receive further follow-up at the NIH Clinical Center.

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2009-12-30
Est. Completion 2011-09-20

What the Registry Record Tells You About NCT01052740

The ClinicalTrials.gov registry entry for NCT01052740 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT01052740 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT01052740 about?

NCT01052740 is a clinical study titled "X-Ray Mammography Standard of Care Protocol". Background: * X-ray mammography is the standard method for breast cancer screening. It is a noninvasive test using x-rays to take pictures of breast tissue and detect any abnormalities. * The National Institutes of Health (NIH) Clinical Center has a breast imaging unit that has been accredited by t...

What is the current status of trial NCT01052740?

This trial is currently completed. The enrollment target is 108 participants. The study started on 2009-12-30. Estimated completion is 2011-09-20.

What conditions does trial NCT01052740 study?

This clinical trial studies the following conditions: Breast Cancer, Atypical Ductal Hyperplasia, Invasive Carcinoma, In Situ Carcinoma, Fibrocystic Changes.

Who is sponsoring clinical trial NCT01052740?

This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01052740 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.